Clinical Trials Browser

Phase 1 × Pancreatic Neoplasms × spartalizumab × Clear all

Esophageal Squamous Cell Carcinoma, Melanoma, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT04152018 2025-05-28

Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

GastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Bile Duct Neoplasms, Carcinoma, Renal Cell, Esophageal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT03716596 2024-09-20

CISPD-2

Phase 1 Terminated

8 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02947165 2022-01-31

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Phase 1 Completed

120 enrolled

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

Clinical Trials

A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands

Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

CISPD-2

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.